|
End-of-day quote
Shenzhen S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 28.32 CNY | -2.75% |
|
-8.23% | -15.59% |
| 09-04 | ApicHope Pharmaceutical Obtains Approval for Sertraline Oral Solution in China | MT |
| 09-04 | ApicHope Pharmaceutical's Gout Drug Meets Primary Endpoint in Drug Trial | MT |
| Market Cap | 12.7B 1.91B 1.71B 1.58B 1.43B 2.67B 182B 2.71B 18.79B 7.5B 94.99B 7.15B 7B 301B | P/E 2026 * |
24.4x | P/E 2027 * | -123x |
|---|---|---|---|---|---|
| Enterprise Value | 12.7B 1.91B 1.71B 1.58B 1.43B 2.67B 182B 2.71B 18.79B 7.5B 94.99B 7.15B 7B 301B | EV / Sales 2026 * |
11.8x | EV / Sales 2027 * | 10.1x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.75% | ||
| 1 week | -8.23% | ||
| Current month | -14.88% | ||
| 1 month | -12.86% | ||
| 3 months | -17.82% | ||
| 6 months | -26.84% | ||
| Current year | -15.59% |
| 1 week | 28.3 |  | 30.55 |
| 1 month | 28.3 | | 33.8 |
| Current year | 28.3 | | 45.88 |
| 1 year | 28.3 | | 56.88 |
| 3 years | 12.74 | | 81.48 |
| 5 years | 12.74 | | 81.48 |
| 10 years | 7.58 | | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
Liang Wen Huang
CHM | Chairman | 50 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/1/26 | Buy | Director | 4,200 | 0.0010% | ||
| 24/11/25 | Buy | Director | 7,000 | 0.0017% | ||
| 1/9/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.75% | -8.23% | -46.94% | +0.18% | 1.96B | |
| +6.15% | +4.80% | +68.33% | +142.07% | 1,148B | |
| +1.24% | +2.52% | +47.03% | +86.60% | 652B | |
| +1.00% | +1.37% | +28.41% | +103.75% | 505B | |
| +0.73% | +2.45% | +54.26% | +66.47% | 384B | |
| +4.09% | +0.01% | +70.07% | +43.41% | 348B | |
| +2.38% | +2.65% | +34.31% | +56.33% | 294B | |
| +2.26% | +0.55% | +3.92% | +27.74% | 264B | |
| +1.55% | +2.60% | +57.28% | +74.36% | 244B | |
| +1.32% | +2.77% | +36.33% | +107.73% | 197B | |
| Average | +1.83% | +0.60% | +35.30% | +70.86% | 403.91B | |
| Weighted average by Cap. | +2.98% | +1.50% | +49.74% | +93.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 162M 145M 134M 121M 227M 15.43B 230M 1.6B 637M 8.08B 608M 595M 25.58B | 1.26B 189M 169M 156M 141M 264M 17.98B 268M 1.86B 742M 9.41B 708M 693M 29.8B |
| Net income | 526M 78.93M 70.69M 65.22M 59.02M 110M 7.52B 112M 778M 310M 3.93B 296M 290M 12.46B | -102M -15.31M -13.71M -12.65M -11.44M -21.4M -1.46B -21.75M -151M -60.2M -763M -57.44M -56.22M -2.42B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CN¥28.32 | -2.75% | 3,134,872 |
| 28/10/26 | CN¥29.12 | +1.22% | 2,711,481 |
| 27/10/26 | CN¥28.77 | -4.86% | 3,550,500 |
| 26/10/26 | CN¥30.24 | -0.10% | 2,734,338 |
| 23/10/26 | CN¥30.27 | +2.47% | 4,424,788 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
